
Recent disruptive cyberattacks on blood suppliers and related establishments have illuminated critical vulnerabilities in the systems and networks that underpin the safe procurement, processing, and distribution of blood and blood components. The Food and Drug Administration (FDA), in light of these incidents, is appealing to blood entities to significantly fortify their cybersecurity practices to ensure the reliable and safe supply









